Effects of cyclosporin and FK-506 on glomerular mesangial cells

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF01428385PMID 7683610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of vascular smooth muscle cell activity by cyclosporin A

  2004cited by this paper
• The synergistic immunosuppressive potential of cyclosporin metabolite combinations.

  1992cited by this paper
• The role of thromboxane and prostacyclin in ciclosporin-induced nephrotoxicity.

  1992cited by this paper
• The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer

  1991cited by this paper
• Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

  1991cited by this paper
• Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations.

  1991cited by this paper
• Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?

  1991cited by this paper
• Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.

  1991cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.

  1991cited by this paper
• CO‐PARTICIPATION OF THROMBOXANE A2 AND LEUKOTRIENE C4 AND D4 IN MEDIATING CYCLOSPORINE‐INDUCED ACUTE RENAL FAILURE

  1991cited by this paper
• THE EFFECT OF CYCLOSPORINE ON AGONIST‐STIMULATED GLOMERULAR AND MESANGIAL CELL VASODILATORY PROSTAGLANDIN PRODUCTION

  1991cited by this paper
• Additive and synergistic effects of cyclosporine metabolites on glomerular mesangial cells.

  1991cited by this paper
• The effects of cyclosporine A, cyclosporine G, and FK 506 upon prostaglandin production in renal mesangial cells in culture.

  1991cited by this paper
• Cyclosporine and FK 506 induced inhibition of renal epithelial cell proliferation.

  1991cited by this paper
• Molecular cloning of human platelet thromboxane A synthase.

  1991cited by this paper
• Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin.

  1991cited by this paper
• Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells.

  1991cited by this paper
• Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.

  1991cited by this paper
• Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase.

  1991cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA.

  1990cited by this paper
• The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.

  1990cited by this paper
• Role of endothelin in cyclosporine-induced glomerular dysfunction.

  1990cited by this paper
• Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.

  1990cited by this paper
• Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells.

  1990cited by this paper
• Structure-activity relationships of cyclosporines. Inhibition of angiotensin II-stimulated prostaglandin release in cultured rat mesangial cells.

  1990cited by this paper
• EVIDENCE THAT ALTERATIONS IN RENAL METABOLISM AND LIPID PEROXIDATION MAY CONTRIBUTE TO CYCLOSPORINE NEPHROTOXICITY

  1990cited by this paper
• Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-alpha 1.

  1989cited by this paper
• Cyclosporine nephrotoxicity: blood volume, sodium conservation, and renal hemodynamics.

  1989cited by this paper
• Development of an enzyme-linked immunosorbent assay of thromboxane B2 using a monoclonal antibody.

  1989cited by this paper
• Actions of cyclosporin A on cultured rat mesangial cells.

  1989cited by this paper
• Cyclosporin A augments vasoconstrictor-induced rise in intracellular free calcium in rat renal mesangial cells.

  1988cited by this paper
• Enhancement of eicosanoid synthesis in mouse peritoneal macrophages by the organic mercury compound thimerosal.

  1988cited by this paper
• Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.

  1986cited by this paper
• Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages.

  1985cited by this paper

• Observation of Cyclosporin A: Sustained Release Intraocular Lens Implantation in Rabbit Eyes

  2022cites this paper
• Tacrolimus Optic Neuropathy

  2018cites this paper
• Effect of immunosuppression on the human mesangial cell cycle

  2014cites this paper
• Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity.

  2011cites this paper
• Effects of cyclosporin a on proliferation of cultured rat mesangial cells

  2008cites this paper
• Studies of immunoglobulin receptors and human proximal tubular cells

  2008cites this paper
• Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes

  2007cites this paper
• FK506, transforming growth factor-beta1 and mesangial matrix synthesis: parallels and differences compared with cyclosporine A.

  2006cites this paper
• Einfluss moderner Immunsuppressiva, ACE-Hemmer, AT1-Rezeptorblocker und Statine auf die Proliferation von Mesangiumzellen aus einer Rattenzellkultur

  2005cites this paper
• Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease

  2003cites this paper
• FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3.

  2002cites this paper
• Expression of DNA topoisomerases in chronic proliferative kidney disease.

  2000cites this paper
• Differential anti-inflammatory effects of immunosuppressive drugs: Cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production

  2000cites this paper
• Effects of cyclosporin A on proliferation of cultured rat mesangial cells.

  1997cites this paper
• Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture

  1997cites this paper
• Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis.

  1994cites this paper